Argent Biopharma (AU:RGT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Argent BioPharma Ltd. has announced the issuance of 1,000,000 fully paid ordinary shares, which are now exempt from the usual on-sale restrictions under section 708A(5) of the Corporations Act 2001. This exemption follows the compliance with necessary legal and financial disclosure obligations, ensuring investors have the required information for an informed assessment of the company’s position and the shares’ rights and liabilities. Argent BioPharma is known for its innovative approaches in the biopharmaceutical sector, particularly in CNS and immunology treatments.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.